Skip to content

Clinical study for the effect of the combination of Shudipingchan prescription and Monoamine oxidase inhibitor on improving early Parkinson‘s Disease symptoms and delaying the progression of the disease

Clinical study for the effect of the combination of Shudipingchan prescription and Monoamine oxidase inhibitor on improving early Parkinson‘s Disease symptoms and delaying the progression of the disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018017
Enrollment
Unknown
Registered
2018-08-27
Start date
2018-10-30
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Treatment group:Selegiline+Shudipingchan granule
Control group:Selegiline+TCM simulant

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age between 30 to 85 years primary PD patient. The diagnosis was based on the MDS diagnostic criteria of 2015, [PD syndrome + no absolute exclusion criteria + > 2 supporting criteria + no warning signs (Red Flegs)]; 2. Hohen-Yahr stage = 2; 3. TCM syndrome differentiation: According to TCM classification, it can be divided into liver and kidney insufficiency type, Qi and blood insufficiency type, qi stagnation and blood stasis type, phlegm-heat and wind-moving type.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women; patients with severe cognitive impairment or psychiatric symptoms; patients with severe liver and kidney insufficiency; patients in other clinical studies or in other clinical studies within the previous 30 days; patients unable to cooperate with the survey.

Design outcomes

Primary

MeasureTime frame
UPDRS;The first time adding anti PD drugs;

Secondary

MeasureTime frame
Activity of Daily Living Scale;PDQ39;

Countries

China

Contacts

Public ContactCanxing Yuan

Longhua Hospital Shanghai University of Traditional Chinese Medicine

ycanxing@hotmai.com+86 13611669686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026